Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$581M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$567M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$477M |
| 4 |
Intel
INTC
|
+$149M |
| 5 |
KraneShares CSI China Internet ETF
KWEB
|
+$125M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$519M |
| 2 |
Microsoft
MSFT
|
+$383M |
| 3 |
Amazon
AMZN
|
+$371M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$202M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$200M |
Sector Composition
| 1 | Technology | 18.12% |
| 2 | Financials | 10.22% |
| 3 | Healthcare | 9.88% |
| 4 | Consumer Discretionary | 7.94% |
| 5 | Industrials | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
SPDR S&P Dividend ETF
SDY
$20.6B
| $3.32M | ﹤0.01% |
27,939
-20
| -0.1% | -$2.37K |
|
1277
TG Therapeutics
TGTX
$5.15B
| $3.3M | ﹤0.01% |
776,508
+675,007
| +665% | +$2.87M |
|
|
ALCE
1278
DELISTED
Alternus Clean Energy, Inc. Class A Common Stock
ALCE
| $3.29M | ﹤0.01% |
+13,400
| New | +$3.29M |
|
1279
Denali Therapeutics
DNLI
$2.14B
| $3.29M | ﹤0.01% |
111,814
+76,430
| +216% | +$2.25M |
|
1280
AMN Healthcare
AMN
$751M
| $3.28M | ﹤0.01% |
29,936
-19,212
| -39% | -$2.11M |
|
1281
Ocugen
OCGN
$334M
| $3.28M | ﹤0.01% |
1,445,637
+1,036,249
| +253% | +$2.35M |
|
1282
Green Plains
GPRE
$641M
| $3.28M | ﹤0.01% |
120,711
-6,321
| -5% | -$172K |
|
|
SAGE
1283
DELISTED
Sage Therapeutics
SAGE
| $3.27M | ﹤0.01% |
101,331
+33,826
| +50% | +$1.09M |
|
1284
Ligand Pharmaceuticals
LGND
$3.24B
| $3.27M | ﹤0.01% |
58,732
+20,359
| +53% | +$1.13M |
|
1285
California Resources
CRC
$4.42B
| $3.27M | ﹤0.01% |
84,885
+20,097
| +31% | +$774K |
|
1286
Universal Health Services
UHS
$11.8B
| $3.26M | ﹤0.01% |
32,369
-17,990
| -36% | -$1.81M |
|
1287
Blue Owl Capital
OWL
$12.2B
| $3.26M | ﹤0.01% |
324,778
+79,385
| +32% | +$796K |
|
|
DEN
1288
DELISTED
Denbury Inc.
DEN
| $3.26M | ﹤0.01% |
54,270
+6,131
| +13% | +$368K |
|
1289
SPDR Bloomberg Convertible Securities ETF
CWB
$4.5B
| $3.25M | ﹤0.01% |
50,394
-1,737
| -3% | -$112K |
|
1290
Pacer US Cash Cows 100 ETF
COWZ
$19.8B
| $3.21M | ﹤0.01% |
74,600
+14,616
| +24% | +$630K |
|
1291
Stellar Bancorp
STEL
$1.61B
| $3.21M | ﹤0.01% |
120,663
+291
| +0.2% | +$7.74K |
|
1292
AB InBev
BUD
$115B
| $3.18M | ﹤0.01% |
58,898
+1,169
| +2% | +$63K |
|
1293
Burlington
BURL
$17.6B
| $3.18M | ﹤0.01% |
23,299
-4,987
| -18% | -$680K |
|
|
TELL
1294
DELISTED
Tellurian Inc.
TELL
| $3.16M | ﹤0.01% |
1,059,562
+317,826
| +43% | +$947K |
|
1295
Bruker
BRKR
$4.87B
| $3.14M | ﹤0.01% |
50,015
-13,056
| -21% | -$819K |
|
1296
Vericel Corp
VCEL
$1.69B
| $3.13M | ﹤0.01% |
124,119
+59,383
| +92% | +$1.5M |
|
1297
Vital Energy
VTLE
$647M
| $3.13M | ﹤0.01% |
45,332
-20,808
| -31% | -$1.43M |
|
|
HOLI
1298
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $3.13M | ﹤0.01% |
211,123
-254
| -0.1% | -$3.76K |
|
|
NS
1299
DELISTED
NuStar Energy L.P.
NS
| $3.12M | ﹤0.01% |
222,782
-62,885
| -22% | -$880K |
|
1300
Relay Therapeutics
RLAY
$700M
| $3.12M | ﹤0.01% |
186,158
+154,898
| +496% | +$2.59M |
|